GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » Market Cap

Cipla (BOM:500087) Market Cap : ₹1,168,900 Mil (As of Dec. 15, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Cipla Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cipla's share price for the quarter that ended in Sep. 2024 was ₹1654. Cipla's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 808 Mil. Therefore, Cipla's market cap for the quarter that ended in Sep. 2024 was ₹1,335,716 Mil.

Cipla's quarterly market cap declined from Mar. 2024 (₹1,206,731 Mil) to Jun. 2024 (₹1,195,501 Mil) but then increased from Jun. 2024 (₹1,195,501 Mil) to Sep. 2024 (₹1,335,716 Mil).

Cipla's annual market cap declined from Mar. 2022 (₹821,740 Mil) to Mar. 2023 (₹726,961 Mil) but then increased from Mar. 2023 (₹726,961 Mil) to Mar. 2024 (₹1,206,731 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cipla's Enterprise Value for Today is ₹1,086,432 Mil.


Cipla Market Cap Historical Data

The historical data trend for Cipla's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Market Cap Chart

Cipla Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 341,037.41 657,468.96 821,740.06 726,960.55 1,206,731.09

Cipla Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 958,133.31 1,006,563.61 1,206,731.09 1,195,501.46 1,335,715.82

Competitive Comparison of Cipla's Market Cap

For the Drug Manufacturers - General subindustry, Cipla's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipla's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Market Cap distribution charts can be found below:

* The bar in red indicates where Cipla's Market Cap falls into.



Cipla Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cipla's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹1494.65*807.367
=₹1,206,731

Cipla's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=₹1654*807.567
=₹1,335,716

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipla  (BOM:500087) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cipla Market Cap Related Terms

Thank you for viewing the detailed overview of Cipla's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipla Business Description

Traded in Other Exchanges
Address
Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines